DDS
MCID: DNY001
MIFTS: 69

Denys-Drash Syndrome (DDS) malady

Genetic diseases, Rare diseases, Nephrological diseases, Reproductive diseases, Endocrine diseases, Fetal diseases, Cancer diseases categories
Download this MalaCard

Summaries for Denys-Drash Syndrome

About this section


Fully expand this MalaCard
NIH Rare Diseases:42 Denys-drash syndrome is a condition that affects the kidneys and genitalia. kidney disease typically begins in the first few months of life, often leading to kidney failure in childhood. in addition, up to 90 percent of people with this condition develop a rare form of kidney cancer known as wilms tumor. males with denys-drash syndrome have gonadal dysgenesis, a condition in which the external genitalia do not look clearly male or clearly female (ambiguous genitalia) or the genitalia appear to be completely female. the testes are also undescended, meaning that they remain in the pelvis, abdomen, or groin. affected females usually have normal genitalia. for this reason, females with this condition may be diagnosed with isolated nephrotic syndrome. denys-drash syndrome is caused by mutations in the wt1 gene. this condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. however, most cases result from new mutations in the gene and occur in people with no history of the disorder in their family. last updated: 10/28/2013

MalaCards based summary: Denys-Drash Syndrome, also known as drash syndrome, is related to gonadal dysgenesis and diffuse mesangial sclerosis, and has symptoms including renal disease/nephropathy, nephrotic syndrome and proteinuria. An important gene associated with Denys-Drash Syndrome is WT1 (Wilms tumor 1), and among its related pathways are TGF-beta/Smad Signaling and Nephrin interactions. The compounds dmrt and hydroxysteroid have been mentioned in the context of this disorder. Affiliated tissues include kidney and testes, and related mouse phenotypes are renal/urinary system and respiratory system.

Disease Ontology:8 An autosomal dominant disease that is characterized by the association of diffuse mesangial sclerosis (dms), male pseudohermaphroditism with a 46,xy karyotype, and nephroblastoma that derives from an abnormality in the wt1 gene (wilms' tumor suppressor gene).

Genetics Home Reference:21 Denys-Drash syndrome is a condition that affects the kidneys and genitalia.

Wikipedia:65 Denys?Drash syndrome (DDS) or Drash syndrome is very rare disorder or syndrome characterized by gonadal... more...

Description from OMIM:46 194080

Aliases & Classifications for Denys-Drash Syndrome

About this section
Sources:
30LifeMap Discovery®, 8Disease Ontology, 9diseasecard, 42NIH Rare Diseases, 20GeneTests, 21Genetics Home Reference, 46OMIM, 10DISEASES, 44Novoseek, 48Orphanet, 62UMLS, 22GTR, 39NCIt, 34MeSH, 57SNOMED-CT, 35MESH via Orphanet, 26ICD10 via Orphanet, 63UMLS via Orphanet
See all sources

Denys-Drash Syndrome, Aliases & Descriptions:

Name: Denys-Drash Syndrome 30 8 9 42 20 21 46 10 44 48 62
Drash Syndrome 42 22 21 48
Wilms Tumor and Pseudohermaphroditism 42 21 48
Nephropathy, Wilms Tumor, and Genital Anomalies 42 21
 
Nephropathy Associated with Male Pseudohermaphroditism and Wilms' Tumor 42
Pseudohermaphroditism, Nephron Disorder and Wilms' Tumor 42
Dds 21


Classifications:



Characteristics (Orphanet epidemiological data):

48
denys-drash syndrome:
Prevalence: <1/1000000; Age of onset: Neonatal/infancy


External Ids:

Disease Ontology8 DOID:3764
NCIt39 C84668
OMIM46 194080
SNOMED-CT57 236385009
MESH via Orphanet35 D030321
ICD10 via Orphanet26 N04.1
UMLS via Orphanet63 C0950121

Related Diseases for Denys-Drash Syndrome

About this section

Diseases related to Denys-Drash Syndrome via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 98)
idRelated DiseaseScoreTop Affiliating Genes
1gonadal dysgenesis31.4NR5A1, WT1
2diffuse mesangial sclerosis30.9WT1, NPHS2, NPHS1, PAX2
3wilms tumor30.6NR5A1, PDGFA, SRD5A1, PAX2, NPHS1, NPHS2
4nephrotic syndrome30.5PAX2, NPHS1, NPHS2, CD2AP, WT1
5nephrosis30.5NPHS2, NPHS1
6diabetic nephropathy30.1TGFB1, PDGFA, NPHS1, NPHS2
7glomerulosclerosis30.0TGFB1, PDGFA, NPHS1, NPHS2, CD2AP, WT1
8glomerulonephritis29.7CD2AP, NPHS2, NPHS1, TGFB1
946xy sex reversal 310.5NR5A1
10gonadoblastoma10.5
11frasier syndrome10.5WT1
12pseudohermaphroditism10.5
13sex cord-gonadal stromal tumor10.3WT1, NR5A1
14burkitt's lymphoma10.3
15mixed gonadal dysgenesis10.3
16hemolytic-uremic syndrome10.3
17congenital diaphragmatic hernia10.3
18kidney disease10.3
19pyloric stenosis10.3
20septate vagina10.3
21hypertension10.3
22artery disease10.3
23abrikosov's tumor10.3WT1, NR5A1
24endotheliitis10.3
25hypospadias10.3WT1, NR5A1, SRD5A1
26cryptorchidism10.3SRD5A1, NR5A1, WT1
27congenital adrenal hyperplasia10.3SRD5A1, NR5A1
28addison's disease10.2NR5A1, WT1
29myocardial infarction10.2
30pallister-hall syndrome10.2MECOM, KLF10
31leydig cell tumor10.2NR5A1, SRD5A1
32leprosy10.2
33nail-patella syndrome10.2PAX2, NPHS2, CD2AP
34ureteral obstruction10.1PDGFA, TGFB1
35klinefelter's syndrome10.1NR5A1, SRD5A1
36acute myocardial infarction10.1
37diabetes mellitus10.1
38obesity10.1
39lepromatous leprosy10.1
40sarcoidosis10.1
41developmental disabilities10.1
42end stage renal failure10.1
43intussusception10.1
44nephritis10.1
45lipoid nephrosis10.1CD2AP, NPHS2, NPHS1
46gingival overgrowth10.1SRD5A1, TGFB1
47membranous glomerulonephritis10.1NPHS1, NPHS2, CD2AP
48primary hyperoxaluria10.0WT1, PAX2, TGFB1
49congenital nephrotic syndrome finnish type10.0NPHS1, NPHS2, CD2AP, WT1
50atherosclerosis9.9

Graphical network of the top 20 diseases related to Denys-Drash Syndrome:



Diseases related to denys-drash syndrome

Symptoms for Denys-Drash Syndrome

About this section

Symptoms by clinical synopsis from OMIM:

194080

Clinical features from OMIM:

194080

Symptoms:

48 (show all 7)
  • renal disease/nephropathy
  • nephrotic syndrome
  • proteinuria
  • male pseudohermaphrodism/lack of virilisation
  • nephroblastoma/wilms tumor
  • chronic arterial hypertension
  • mixed gonadal dysgenesis

HPO human phenotypes related to Denys-Drash Syndrome:

(show all 24)
id Description Frequency HPO Source Accession
1 male pseudohermaphroditism hallmark (90%) HP:0000037
2 proteinuria hallmark (90%) HP:0000093
3 nephrotic syndrome hallmark (90%) HP:0000100
4 nephropathy hallmark (90%) HP:0000112
5 nephroblastoma (wilms tumor) hallmark (90%) HP:0002667
6 hypertension typical (50%) HP:0000822
7 gonadal dysgenesis occasional (7.5%) HP:0000133
8 autosomal dominant inheritance HP:0000006
9 ambiguous genitalia, male HP:0000033
10 male pseudohermaphroditism HP:0000037
11 ambiguous genitalia, female HP:0000061
12 focal segmental glomerulosclerosis HP:0000097
13 nephrotic syndrome HP:0000100
14 nephropathy HP:0000112
15 gonadal dysgenesis HP:0000133
16 ovarian gonadoblastoma HP:0000149
17 congenital diaphragmatic hernia HP:0000776
18 hypertension HP:0000822
19 somatic mutation HP:0001428
20 diffuse mesangial sclerosis HP:0001967
21 nephroblastoma (wilms tumor) HP:0002667
22 gonadal tissue inappropriate for external genitalia or chromosomal sex HP:0003248
23 stage 5 chronic kidney disease HP:0003774
24 true hermaphroditism HP:0010459

Drugs & Therapeutics for Denys-Drash Syndrome

About this section

Drug clinical trials:

Search ClinicalTrials for Denys-Drash Syndrome

Search NIH Clinical Center for Denys-Drash Syndrome

Genetic Tests for Denys-Drash Syndrome

About this section

Genetic tests related to Denys-Drash Syndrome:

id Genetic test Affiliating Genes
1 Denys-Drash Syndrome20 WT1
2 Drash Syndrome22

Anatomical Context for Denys-Drash Syndrome

About this section

MalaCards organs/tissues related to Denys-Drash Syndrome:

32
Kidney, Testes

LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine

Cells/anatomical compartments in embryo or adult related to Denys-Drash Syndrome:
id TissueAnatomical CompartmentCell Relevance
1 KidneyMetanephric MesenchymeMetanephric Mesenchyme Cells Potential therapeutic candidate, affected by disease

Animal Models for Denys-Drash Syndrome or affiliated genes

About this section

Publications for Denys-Drash Syndrome

About this section

Articles related to Denys-Drash Syndrome:

(show top 50)    (show all 78)
idTitleAuthorsYear
1
Clinical features and an atypical WT1 mutant site in a child with incomplete Denys-Drash syndrome. (24625882)
2014
2
An unusual presentation of denys-drash syndrome due to bigenic disease. (24379226)
2014
3
Denys-Drash syndrome, septated vagina and low level of anti-Mullerian hormone in male neonate. (25077094)
2014
4
A familial WT1 mutation associated with incomplete Denys-Drash syndrome. (23715653)
2013
5
Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy. (23729537)
2013
6
A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome. (21559934)
2011
7
Clinical pictures and novel mutations of WT1-associated Denys-Drash syndrome in two Chinese children. (21851196)
2011
8
A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes. (19797313)
2010
9
The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome. (20562648)
2010
10
Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome. (18197048)
2008
11
Denys-Drash syndrome and congenital diaphragmatic hernia: another case with the 1097G &gt; A(Arg366His) mutation. (18203154)
2008
12
Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396). (18040647)
2008
13
Mixed gonadal dysgenesis and Denys-Drash syndrome: urologists should screen for nephrotic syndrome. (18163932)
2007
14
Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome. (17267748)
2007
15
A novel WT1 missense mutation presenting with Denys-Drash syndrome and cortical atrophy. (16303781)
2006
16
Denys-Drash syndrome (DDS). (16823575)
2006
17
Hydrothorax in a patient with Denys-Drash syndrome associated with a diaphragmatic defect. (16932893)
2006
18
Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. (15910385)
2005
19
A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome. (15503171)
2005
20
Denys-Drash syndrome. (15758579)
2005
21
Denys-Drash syndrome. (15026863)
2004
22
A novel mutation of WT1 exon 9 in a patient with Denys-Drash syndrome and pyloric stenosis. (15349765)
2004
23
The dysregulated glomerular cell growth in Denys-Drash syndrome. (15232745)
2004
24
Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis. (12915483)
2003
25
A necropsy case of Denys-Drash syndrome with a WT1 mutation in exon 7. (12161615)
2002
26
Wilms tumor in a pediatric renal transplant recipient with unexpected Denys-Drash syndrome. (12493420)
2002
27
Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome. (11519891)
2001
28
Pulmonary dysplasia, Denys-Drash syndrome and Wilms tumor 1 gene mutation in twins. (11322369)
2001
29
Association of partial gonadal dysgenesis, nephropathy and WT1 gene mutation without Wilms' tumor: incomplete Denys-Drash syndrome. (11393579)
2001
30
Novel WT1 exon 9 mutation (D396Y) in a patient with early onset Denys Drash syndrome. (10738002)
2000
31
Hemolytic uremic syndrome associated with Denys-Drash syndrome. (11045393)
2000
32
A novel missense mutation of the WT1 gene causing Denys-Drash syndrome with exceptionally mild renal manifestations. (10799199)
2000
33
A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. (10077614)
1999
34
Unexpected Wilms' tumor in a pediatric renal transplant recipient: suspected Denys-Drash syndrome. (10371996)
1999
35
Renal transplantation in the management of bilateral Wilms' tumour (BWT) and of Denys-Drash syndrome (DDS). (9641183)
1998
36
No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with Denys-Drash syndrome. (9681076)
1998
37
Regulation of renal EGF receptor expression is normal in Denys-Drash syndrome. (9291179)
1997
38
Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation. (9125334)
1996
39
A novel mutation H373Y in the Wilms' tumor suppressor gene, WT1, associated with Denys-Drash syndrome. (8956030)
1996
40
Nephropathy with Wilms tumour or gonadal dysgenesis: incomplete Denys-Drash syndrome or separate diseases? (7556327)
1995
41
Aberrant proteoglycan composition of the glomerular basement membrane in a patient with Denys-Drash syndrome. (8808212)
1995
42
WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. (7959750)
1994
43
Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome. (8281163)
1993
44
A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome. (8281164)
1993
45
A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. (8098976)
1993
46
A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. (8381368)
1993
47
Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. (8229473)
1993
48
Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. (8388765)
1993
49
Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development. (1338905)
1992
50
Inherited WT1 mutation in Denys-Drash syndrome. (1327525)
1992

Variations for Denys-Drash Syndrome

About this section

UniProtKB/Swiss-Prot genetic disease variations for Denys-Drash Syndrome:

64 (show all 24)
id Symbol AA change Variation ID SNP ID
1WT1p.Cys330TyrVAR_007743
2WT1p.Cys360GlyVAR_007744
3WT1p.Arg366CysVAR_007745
4WT1p.Arg366HisVAR_007746
5WT1p.His373GlnVAR_007747
6WT1p.Arg394TrpVAR_007750
7WT1p.Asp396AsnVAR_007751
8WT1p.Asp396GlyVAR_007752
9WT1p.Met342ArgVAR_015054
10WT1p.Cys355TyrVAR_015055
11WT1p.His373TyrVAR_015056
12WT1p.His377ArgVAR_015057
13WT1p.Cys385ArgVAR_015058
14WT1p.Cys388PheVAR_015059
15WT1p.Arg394GlnVAR_015061
16WT1p.Leu398ProVAR_015062
17WT1p.Cys360TyrVAR_043800
18WT1p.Arg366LeuVAR_043802
19WT1p.Gln369ProVAR_043803
20WT1p.Cys388TyrVAR_043806
21WT1p.Arg394ProVAR_043808
22WT1p.Asp396TyrVAR_043809
23WT1p.His401TyrVAR_043811
24WT1p.His405ArgVAR_043812

Clinvar genetic disease variations for Denys-Drash Syndrome:

6 (show all 11)
id Gene Name Type Significance SNP ID Assembly Location
1WT1NM_000378.4(WT1): c.1333C> T (p.Arg445Trp)single nucleotide variantPathogenicrs121907900GRCh37Chr 11, 32413566: 32413566
2WT1NM_000378.4(WT1): c.1250G> A (p.Arg417His)single nucleotide variantPathogenicrs121907901GRCh37Chr 11, 32414250: 32414250
3WT1NM_000378.4(WT1): c.1340A> G (p.Asp447Gly)single nucleotide variantPathogenicrs121907902GRCh37Chr 11, 32413559: 32413559
4WT1NM_000378.4(WT1): c.1339G> A (p.Asp447Asn)single nucleotide variantPathogenicrs28941778GRCh37Chr 11, 32413560: 32413560
5WT1NM_000378.4(WT1): c.1334G> C (p.Arg445Pro)single nucleotide variantPathogenicrs121907903GRCh37Chr 11, 32413565: 32413565
6WT1NM_000378.4(WT1): c.1142G> A (p.Cys381Tyr)single nucleotide variantPathogenicrs121907904GRCh37Chr 11, 32417859: 32417859
7WT1NM_001198551.1(WT1): c.787+14G> Asingle nucleotide variantPathogenicGRCh38Chr 11, 32391967: 32391967
8WT1NM_000378.4(WT1): c.1282C> T (p.His428Tyr)single nucleotide variantPathogenicrs28942089GRCh37Chr 11, 32414218: 32414218
9WT1NM_000378.4(WT1): c.1231T> G (p.Cys411Gly)single nucleotide variantPathogenicrs121907905GRCh37Chr 11, 32414269: 32414269
10WT1NM_000378.4(WT1): c.1237C> T (p.Arg413Ter)single nucleotide variantPathogenicrs121907906GRCh37Chr 11, 32414263: 32414263
11WT1NM_000378.4(WT1): c.1272C> G (p.His424Gln)single nucleotide variantPathogenicrs121907907GRCh37Chr 11, 32414228: 32414228

Expression for genes affiliated with Denys-Drash Syndrome

About this section
Expression patterns in normal tissues for genes affiliated with Denys-Drash Syndrome

Search GEO for disease gene expression data for Denys-Drash Syndrome.

Pathways for genes affiliated with Denys-Drash Syndrome

About this section

Pathways related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.9PAX2, TGFB1
29.9CD2AP, NPHS1
39.7PDGFA, TGFB1
49.6CD2AP, NPHS2, NPHS1
59.5TGFB1, PDGFA, WT1
6
Show member pathways
MAPK signaling pathway37
9.3PDGFA, MECOM, TGFB1

Compounds for genes affiliated with Denys-Drash Syndrome

About this section

Compounds related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

(show all 23)
idCompoundScoreTop Affiliating Genes
1dmrt4410.3WT1, NR5A1
2hydroxysteroid4410.0NR5A1, SRD5A1
3puromycin aminonucleoside449.9NPHS1, NPHS2, CD2AP
4calcitriol44 61 24 1112.6WT1, SRD5A1, TGFB1
5sildenafil28 44 50 24 1113.6TGFB1, SRD5A1
6creatinine449.6TGFB1, NPHS1, NPHS2, WT1
7ribonucleic acid449.5TGFB1, PDGFA, NR5A1, WT1
812-o-tetradecanoylphorbol 13-acetate449.5WT1, PDGFA, TGFB1
9progesterone44 28 61 24 1113.3SRD5A1, PDGFA, NR5A1, WT1
10glutamine449.1WT1, SRD5A1, SAFB, TGFB1
11indomethacin44 28 61 1112.1NPHS1, SRD5A1, TGFB1
12vegf449.0TGFB1, SRD5A1, PDGFA, NPHS1, WT1
13testosterone44 61 24 1112.0SAFB, SRD5A1, NR5A1, WT1
14dexamethasone44 50 28 1112.0NPHS1, PDGFA, SRD5A1, TGFB1
15oligonucleotide448.9TGFB1, SAFB, PDGFA, NR5A1, WT1
16lipid448.8SAFB, NR5A1, NPHS1, NPHS2, CD2AP
17serine448.7TGFB1, PAX2, SAFB, NR5A1, NPHS1, WT1
18tyrosine448.6PAX2, SAFB, PDGFA, NPHS1, NPHS2, WT1
19zinc44 249.6SAFB, MECOM, PDGFA, NR5A1, KLF10, WT1
20vitamin d448.5WT1, NR5A1, PDGFA, SRD5A1, SAFB, TGFB1
21steroid448.4SAFB, SRD5A1, NR5A1, NPHS1, NPHS2, CD2AP
22estrogen448.2TGFB1, SAFB, SRD5A1, PDGFA, NR5A1, KLF10
23retinoic acid44 249.2TGFB1, SAFB, SRD5A1, PDGFA, NR5A1, NPHS1

GO Terms for genes affiliated with Denys-Drash Syndrome

About this section

Cellular components related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1slit diaphragmGO:03605710.0NPHS2, NPHS1
2microvillusGO:0059029.7PDGFA, TGFB1
3protein complexGO:0432349.4NPHS2, NPHS1, PAX2
4nuclear speckGO:0166079.3SRSF6, MECOM, WT1
5nucleusGO:0056346.8TGFB1, PAX2, SAFB, SRSF6, MECOM, ZNF274

Biological processes related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

(show all 24)
idNameGO IDScoreTop Affiliating Genes
1metanephric epithelium developmentGO:07220710.4PAX2, WT1
2negative regulation of female gonad developmentGO:200019510.3WT1, NR5A1
3mesenchymal to epithelial transitionGO:06023110.3WT1, PAX2
4metanephric mesenchyme developmentGO:07207510.3PAX2, WT1
5positive regulation of male gonad developmentGO:200002010.3WT1, NR5A1
6glomerular basement membrane developmentGO:03283610.3WT1, NPHS1
7tissue developmentGO:00988810.2WT1, NR5A1
8adrenal gland developmentGO:03032510.2WT1, NR5A1
9negative regulation of programmed cell deathGO:04306910.2MECOM, PAX2
10positive regulation of branching involved in ureteric bud morphogenesisGO:09019010.1PAX2, TGFB1
11sex determinationGO:00753010.1SRD5A1, WT1
12camera-type eye developmentGO:04301010.1PAX2, WT1
13protein kinase B signalingGO:04349110.0PAX2, TGFB1
14ureteric bud developmentGO:0016579.9WT1, TGFB1
15hormone metabolic processGO:0424459.9SAFB, NR5A1
16excretionGO:0075889.8NPHS2, NPHS1
17positive regulation of MAP kinase activityGO:0434069.7PDGFA, TGFB1
18transforming growth factor beta receptor signaling pathwayGO:0071799.7KLF10, PDGFA, TGFB1
19cell-cell signalingGO:0072679.6KLF10, NR5A1, PDGFA
20negative regulation of transcription, DNA-templatedGO:0458929.6TGFB1, PAX2, MECOM, WT1
21negative regulation of transcription from RNA polymerase II promoterGO:0001229.6TGFB1, PAX2, KLF10, WT1
22positive regulation of transcription, DNA-templatedGO:0458939.5TGFB1, PAX2, MECOM, WT1
23inner ear developmentGO:0488399.4PDGFA, TGFB1
24positive regulation of transcription from RNA polymerase II promoterGO:0459448.8WT1, NR5A1, MECOM, SAFB, PAX2, TGFB1

Molecular functions related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1C2H2 zinc finger domain bindingGO:07074210.0WT1, PAX2
2protein bindingGO:0055155.7WT1, TGFB1, PAX2, SAFB, MECOM, ZNF274

Products for genes affiliated with Denys-Drash Syndrome

About this section
  • Antibodies
  • Proteins
  • Lysates

Sources for Denys-Drash Syndrome

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet